Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.

Cefodizime is a new expanded-spectrum cephalosporin for parenteral use which possesses a broad antibacterial spectrum and potent antibacterial activity and is stable against most beta-lactamases. The aim of this study was to assess the pharmacokinetics of cefodizime, administered intravenously, over...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lenfant, B, Namour, F, Logeais, C, Coussediere, D, Rivault, O, Bryskier, A, Surjus, A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162877/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8540712/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.9.2037
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!